| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 14558* | 2021 |
| Long-Lived C. elegans daf-2 Mutants Are Resistant to Bacterial Pathogens DA Garsin, JM Villanueva, J Begun, DH Kim, CD Sifri, SB Calderwood, ... Science 300 (5627), 1921-1921, 2003 | 747 | 2003 |
| Caenorhabditis elegans as a Model Host for Staphylococcus aureus Pathogenesis CD Sifri, J Begun, FM Ausubel, SB Calderwood Infection and immunity 71 (4), 2208-2217, 2003 | 453 | 2003 |
| Upadacitinib induction and maintenance therapy for Crohn’s disease EV Loftus Jr, J Panés, AP Lacerda, L Peyrin-Biroulet, G D’Haens, ... New England Journal of Medicine 388 (21), 1966-1980, 2023 | 434 | 2023 |
| High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22 M Gulhane, L Murray, R Lourie, H Tong, YH Sheng, R Wang, A Kang, ... Scientific reports 6 (1), 28990, 2016 | 403 | 2016 |
| The worm has turned–microbial virulence modeled in Caenorhabditis elegans CD Sifri, J Begun, FM Ausubel Trends in microbiology 13 (3), 119-127, 2005 | 367 | 2005 |
| Crystal structure of an Xrcc4–DNA ligase IV complex BL Sibanda, SE Critchlow, J Begun, XY Pei, SP Jackson, TL Blundell, ... Nature structural biology 8 (12), 1015-1019, 2001 | 347 | 2001 |
| IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans A de Luca, SP Smeekens, A Casagrande, R Iannitti, KL Conway, ... Proceedings of the National Academy of Sciences 111 (9), 3526-3531, 2014 | 338 | 2014 |
| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 321* | 2017 |
| Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised … BE Sands, PM Irving, T Hoops, JL Izanec, LL Gao, C Gasink, ... The Lancet 399 (10342), 2200-2211, 2022 | 307 | 2022 |
| MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota M Koyama, P Mukhopadhyay, IS Schuster, AS Henden, J Hülsdünker, ... Immunity 51 (5), 885-898. e7, 2019 | 264 | 2019 |
| The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for ubiquitin-dependent autophagy of intracellular Salmonella Typhimurium A Huett, RJ Heath, J Begun, SO Sassi, LA Baxt, JM Vyas, MB Goldberg, ... Cell host & microbe 12 (6), 778-790, 2012 | 256 | 2012 |
| Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled … BG Feagan, BE Sands, WJ Sandborn, M Germinaro, M Vetter, J Shao, ... The Lancet Gastroenterology & Hepatology 8 (4), 307-320, 2023 | 254 | 2023 |
| Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis M Beaudoin, P Goyette, G Boucher, KS Lo, MA Rivas, C Stevens, ... PLoS genetics 9 (9), e1003723, 2013 | 248 | 2013 |
| Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses J Begun, JM Gaiani, H Rohde, D Mack, SB Calderwood, FM Ausubel, ... PLoS pathogens 3 (4), e57, 2007 | 246 | 2007 |
| Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application RV Bryant, AB Friedman, EK Wright, KM Taylor, J Begun, G Maconi, ... Gut 67 (5), 973-985, 2018 | 196 | 2018 |
| Genetic coding variant in GPR65 alters lysosomal pH and links lysosomal dysfunction with colitis risk KG Lassen, CI McKenzie, M Mari, T Murano, J Begun, LA Baxt, G Goel, ... Immunity 44 (6), 1392-1405, 2016 | 155 | 2016 |
| Defining transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement JFKF Ilvemark, T Hansen, TM Goodsall, JB Seidelin, H Al-Farhan, ... Journal of Crohn's and Colitis 16 (4), 554-580, 2022 | 154 | 2022 |
| Staphylococcus aureus Virulence Factors Identified by Using a High-Throughput Caenorhabditis elegans-Killing Model J Begun, CD Sifri, S Goldman, SB Calderwood, FM Ausubel Infection and immunity 73 (2), 872-877, 2005 | 128 | 2005 |
| DAF-16-Dependent Suppression of Immunity During Reproduction in Caenorhabditis elegans S Miyata, J Begun, ER Troemel, FM Ausubel Genetics 178 (2), 903-918, 2008 | 125 | 2008 |
